These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35728038)

  • 1. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
    Johnson BA; Zhou Y; Lokugamage KG; Vu MN; Bopp N; Crocquet-Valdes PA; Kalveram B; Schindewolf C; Liu Y; Scharton D; Plante JA; Xie X; Aguilar P; Weaver SC; Shi PY; Walker DH; Routh AL; Plante KS; Menachery VD
    PLoS Pathog; 2022 Jun; 18(6):e1010627. PubMed ID: 35728038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
    Johnson BA; Zhou Y; Lokugamage KG; Vu MN; Bopp N; Crocquet-Valdes PA; Kalveram B; Schindewolf C; Liu Y; Scharton D; Plante JA; Xie X; Aguilar P; Weaver SC; Shi PY; Walker DH; Routh AL; Plante KS; Menachery VD
    bioRxiv; 2022 Mar; ():. PubMed ID: 34671771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2.
    Wu H; Xing N; Meng K; Fu B; Xue W; Dong P; Tang W; Xiao Y; Liu G; Luo H; Zhu W; Lin X; Meng G; Zhu Z
    Cell Host Microbe; 2021 Dec; 29(12):1788-1801.e6. PubMed ID: 34822776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load.
    Mourier T; Shuaib M; Hala S; Mfarrej S; Alofi F; Naeem R; Alsomali A; Jorgensen D; Subudhi AK; Ben Rached F; Guan Q; Salunke RP; Ooi A; Esau L; Douvropoulou O; Nugmanova R; Perumal S; Zhang H; Rajan I; Al-Omari A; Salih S; Shamsan A; Al Mutair A; Taha J; Alahmadi A; Khotani N; Alhamss A; Mahmoud A; Alquthami K; Dageeg A; Khogeer A; Hashem AM; Moraga P; Volz E; Almontashiri N; Pain A
    Nat Commun; 2022 Feb; 13(1):601. PubMed ID: 35105893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen Synthase Kinase-3 Interaction Domain Enhances Phosphorylation of SARS-CoV-2 Nucleocapsid Protein.
    Yun JS; Song H; Kim NH; Cha SY; Hwang KH; Lee JE; Jeong CH; Song SH; Kim S; Cho ES; Kim HS; Yook JI
    Mol Cells; 2022 Dec; 45(12):911-922. PubMed ID: 36572560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
    Franco-Muñoz C; Álvarez-Díaz DA; Laiton-Donato K; Wiesner M; Escandón P; Usme-Ciro JA; Franco-Sierra ND; Flórez-Sánchez AC; Gómez-Rangel S; Rodríguez-Calderon LD; Barbosa-Ramirez J; Ospitia-Baez E; Walteros DM; Ospina-Martinez ML; Mercado-Reyes M
    Infect Genet Evol; 2020 Nov; 85():104557. PubMed ID: 32950697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico characterization of mutations circulating in SARS-CoV-2 structural proteins.
    Periwal N; Rathod SB; Pal R; Sharma P; Nebhnani L; Barnwal RP; Arora P; Srivastava KR; Sood V
    J Biomol Struct Dyn; 2022 Nov; 40(18):8216-8231. PubMed ID: 33797336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    Lista MJ; Winstone H; Wilson HD; Dyer A; Pickering S; Galao RP; De Lorenzo G; Cowton VM; Furnon W; Suarez N; Orton R; Palmarini M; Patel AH; Snell L; Nebbia G; Swanson C; Neil SJD
    J Virol; 2022 Dec; 96(23):e0125022. PubMed ID: 36350154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis.
    McGrath ME; Xue Y; Dillen C; Oldfield L; Assad-Garcia N; Zaveri J; Singh N; Baracco L; Taylor LJ; Vashee S; Frieman MB
    Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2204717119. PubMed ID: 36040867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
    Gori Savellini G; Anichini G; Cusi MG
    Virus Res; 2023 Jul; 332():199134. PubMed ID: 37192725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.
    Nguyen A; Zhao H; Myagmarsuren D; Srinivasan S; Wu D; Chen J; Piszczek G; Schuck P
    Elife; 2024 Jun; 13():. PubMed ID: 38941236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity.
    Shuaib M; Adroub S; Mourier T; Mfarrej S; Zhang H; Esau L; Alsomali A; Alofi FS; Ahmad AN; Shamsan A; Khogeer A; Hashem AM; Almontashiri NAM; Hala S; Pain A
    Genome Med; 2023 Jul; 15(1):54. PubMed ID: 37475040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of SARS-CoV-2 to ACE2
    Li K; Verma A; Li P; Ortiz ME; Hawkins GM; Schnicker NJ; Szachowicz PJ; Pezzulo AA; Wohlford-Lenane CL; Kicmal T; Meyerholz DK; Gallagher T; Perlman S; McCray PB
    J Virol; 2024 Jan; 98(1):e0151023. PubMed ID: 38168680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of
    Ahmadi K; Shahbazi B; Zakeri AJ; Gouklani H
    J Biomol Struct Dyn; 2023; 41(21):11415-11430. PubMed ID: 36576175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.